More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.37B
EPS
6.72
P/E ratio
8.8
Price to sales
0.59
Dividend yield
2.05%
Beta
0.567641
Previous close
$65.40
Today's open
$64.71
Day's range
$63.94 - $65.39
52 week range
$51.04 - $100
show more
CEO
Bruce L. Caswell
Employees
37200
Headquarters
McLean, VA
Exchange
New York Stock Exchange
Shares outstanding
52357763
Issue type
Common Stock
Industrials
Corporate Services
Countdown to Maximus (MMS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Maximus (MMS) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Zacks Investment Research • Nov 16, 2026

MMS Stock Rises 15.7% in Three Months: Here's What You Should Know
Maximus shares rise 15.7% in three months, fueled by defense expansion, AI-driven efficiency gains and disciplined capital allocation.
Zacks Investment Research • Nov 13, 2026

Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach
Maximus NYSE: MMS said it has agreed to acquire privately held Agile Defense for $660 million, with a potential future earn-out of up to $50 million, as the government-services company seeks to expand its presence in defense, national security and technology-intensive federal missions.
MarketBeat • Oct 21, 2026

Maximus, Inc. (MMS) M&A Call Transcript
Maximus, Inc. (MMS) M&A Call Transcript
Seeking Alpha • Oct 20, 2026

Maximus: A Discount To Peers, Even If The Recent Contract Change Is Permanent
Maximus cut fiscal 2026 adjusted EPS guidance to $7.90-$8.20 after the VA paused performance incentive payments in its medical exam program from July 1 through Dec. 31, 2026. At $55.18, MMS trades at 6.9x the $8.05 guidance average. Without the incentives, our math puts annual adjusted EPS near $7, or 7.9x, still below every peer. MMS trades at 8.2x trailing earnings against 11.5x for Leidos and 12x for Booz Allen, with a 15% trailing free cash flow yield and the lowest leverage in its peer group.
Seeking Alpha • Sep 24, 2026

Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Maximus faces an earnings reset as paused VA incentives cut profit and cash-flow guidance, testing whether service and tech gains can rebuild momentum.
Zacks Investment Research • Aug 12, 2026

Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus trades at a deep earnings discount, but federal procurement delays and weak award conversion cloud the timing of a recovery.
Zacks Investment Research • Aug 12, 2026

Maximus Q3 Earnings Call Highlights
Maximus NYSE: MMS reported fiscal 2026 third-quarter revenue of $1.28 billion, with adjusted EBITDA margin of 15.0% and adjusted diluted earnings per share of $2.22. Revenue was in line with the company's expectations, while adjusted EBITDA margin improved from 14.7% a year earlier and adjusted EPS rose from $2.16.
MarketBeat • Aug 8, 2026

Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript
Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript
Seeking Alpha • Aug 7, 2026

Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
MMS beats fiscal Q3 earnings estimates but misses on revenues, while higher margins contrast with softer sales and reduced 2026 profit guidance.
Zacks Investment Research • Aug 7, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Maximus Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.